# In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)

> **NCT00177190** · — · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 8 (actual)

## Conditions studied

- Cutaneous T-cell Lymphoma
- Sezary Syndrome
- Mycosis Fungoides

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00177190
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2005-01
- **Final completion:** 2006-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2014-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00177190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00177190, "In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00177190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
